Investigation of the Interplay Between Local Oral Inflammation, Microbiota and Systemic Immune Responses.
← catalyst calendarNCT06966492 · readout ≤ 315 d
Sponsored by Colgate Palmolive (industry) · CL — their whole pipeline →. With The University of Texas Health Science Center, Houston.
Phase
Phase 4
Status
Not yet recruiting
Study type
Interventional
Design
Randomized · Triple · Basic science
Enrollment
20estimated
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | Jun 2026 | estimated | When the study began enrolling |
| Primary completion | Jun 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Jun 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2025-05-12 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-05-26 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Gingival Inflammation
Intervention
- Drug: Stannous Fluoride Toothpaste (SnF)
Primary outcome
what the primary-completion date above is the date OFGingival Bleeding Index described by Ainamo & Bay, 1976
measured From enrollment and at each successive visit until to the end of the study
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed